Morquio Syndrome Treatment Market Size, Share, Growth Analysis, By Treatment(Enzyme Replacement Therapy, Other.), By Disease Type(Morquio A, Morquio B), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region - Industry Forecast 2025-2032

Morquio Syndrome Treatment Market size was valued at USD 95.72 Million in 2023 and is poised to grow from USD 104.85 Million in 2024 to USD 206.56 Million by 2032, growing at a CAGR of 9.54% during the forecast period (2025-2032).

An uncommon inherited metabolic disorder that typically affects the skeleton is referred to as Morquio syndrome, commonly known as MPS IV. Morquio syndrome is recognized as a member of the mucopolysaccharidosis group of illnesses (MPS). The body's inability to break down long sugar chains known as glycosaminoglycans is a hallmark of MPS.

One of the key factors propelling the growth of the mosquito syndrome treatment market is the rise in the number of people suffering from the condition globally. Increased government and corporate backing, as well as an increase in the demand for specific medications to treat the syndrome's sequelae, all contribute to the market's rapid expansion. The market is also impacted by the rise in mergers and partnerships between manufacturers to improve treatment alternatives. Additionally, the market for treatments for Morquio syndrome is positively impacted by the rise in healthcare spending, changes in lifestyle, technological advancements, and the occurrence of genetic illnesses. Additionally, the expansion of clinical trials creates lucrative prospects for market participants throughout the projection period of 2022 to 2028.

On the other hand, it is expected that weak reimbursement policies, particularly in the price-sensitive industry, and high production costs may restrain market expansion. The morquio syndrome treatment market is expected to have difficulties during the forecast period of 2022-2028 due to low treatment awareness.

US Morquio Syndrome Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.